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Background
The EuroCMR registry determined indications, image
quality, safety and impact on patient management of
clinical routine CMR in a multi-national European
setting.
Furthermore, interim analyses of two specific proto-
cols evaluating the prognostic potential of CMR in
patients with coronary artery disease (CAD) and hyper-
trophic cardiomyopathy (HCM) are presented.
Methods
Multi-center registry with consecutive enrollment of
patients in 57 centers in 15 countries [1].
Results
27,781 patients were enrolled. The most frequent indica-
tions were risk stratification in CAD/ischemia (34.2%),
workup of cardiomyopathies (32.2%) and assessment of
viability (14.6%). Image quality was diagnostic in 98%.
Severe complications were rare (0.03%).
In 61.8% CMR findings had an impact on patient
management. In 8.7% the final diagnosis changed based
on CMR findings (Table 1).
Kaplan-Meier survival curves of the interim analyses
showed low adverse event rates in patients with sus-
pected CAD with a normal stress CMR (1.0% per year),
and in HCM without delayed enhancement (2.7% per
year).
Conclusions
The most important CMR indications in Europe are risk
stratification in suspected CAD/ischemia, work-up of
cardiomyopathies and assessment of viability. CMR is a
safe procedure, has diagnostic image quality in more
than 98% of cases, and its results have a strong impact
on patient management. Interim analyses underscore
the prognostic value of clinical routine CMR in patients
with CAD and HCM.
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All (from n = 27781) 32.2% 34.2% 14.6%
New diagnosis 11.4% 8.1% 5.3%
Therapeutic consequences:
Change in medication 25.3% 24.3% 33.2%
Invasive procedure 6.9% 23.1% 24.2%






Wagner et al. Journal of Cardiovascular Magnetic
Resonance 2013, 15(Suppl 1):O96
http://www.jcmr-online.com/content/15/S1/O96
© 2013 Wagner et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Author details
1Cardiology, Comprehensive Cardiology, Stamford, CT, USA. 2Cardiology,
Contilia Heart and Vascular Center, Essen, Germany. 3Cardiology, C.N.R./
Regione Toscana “G. Monasterio Foundation”, Pisa, Italy. 4Cardiology, Cardiac
MR Centre, University Hospital (CHUV) Lausanne, Lausanne, Switzerland.
5Cardiology, VU Medical Centre, Amsterdam, Netherlands. 6Cardiology,
Hospital Agatharied, Hausham, Germany. 7Cardiology, Klinikum Ludwigsburg,
Ludwigsburg, Germany. 8Barts and The London NIHR Biomedical Research
Unit, The London Chest Hospital, London, UK. 9Division of Imaging Sciences,
King’s College London BHF, London, UK. 10CMR Unit, Royal Brompton
Hospital, London, UK. 11Internal Medicine, Krankenhaus Benrath, Düsseldorf,
Germany. 12Cardiology, Donauklinikum Tulln, Tulln, Austria. 13Department of
Statistics, Institut für Herzinfarktforschung, Ludwigshafen, Germany.
14Cardiology, Robert Bosch Medical Center, Stuttgart, Germany.
Published: 30 January 2013
Reference
1. Wagner A, et al:. J Cardiovasc Magn Resn 2009.
doi:10.1186/1532-429X-15-S1-O96
Cite this article as: Wagner et al.: European Cardiovascular Magnetic
Resonance (EuroCMR) registry - multi national tesults from 57 centers
in 15 countries. Journal of Cardiovascular Magnetic Resonance 2013 15
(Suppl 1):O96.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Wagner et al. Journal of Cardiovascular Magnetic
Resonance 2013, 15(Suppl 1):O96
http://www.jcmr-online.com/content/15/S1/O96
Page 2 of 2
